Colistimethate for Injection USP 150 mg

Colistimethate for Injection USP 150 mg is a powder for solution used for severe bacterial infections. This antibiotic is administered intramuscularly and is manufactured by Marcan Pharmaceuticals Inc. in Canada.

Colistimethate Sodium is primarily used to treat serious bacterial infections, particularly those caused by gram-negative bacteria. It is often considered when other antibiotics are ineffective. This medication is typically administered intramuscularly and is used in clinical settings for severe infections.

Common effects of Colistimethate Sodium may include localized reactions at the injection site, such as pain or swelling. Systemic effects can include kidney issues and neurological symptoms. Always consult a healthcare provider for personalized advice.

Colistimethate for Injection USP 150 mg should be handled with care. It is important to follow proper administration guidelines to minimize the risk of side effects. Patients with pre-existing kidney conditions should use this medication under close medical supervision.

Colistimethate Sodium may interact with other medications, particularly those that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain other substances may also affect the efficacy of this antibiotic.